We wouldn't blame Bonesupport Holding AB (publ) (STO:BONEX) shareholders if they were a little worried about the fact that Lennart Johansson, the Independent Chairman of the Board recently netted about kr8.4m selling shares at an average price of kr337. That's a big disposal, and it decreased their holding size by 15%, which is notable but not too bad.
The Last 12 Months Of Insider Transactions At Bonesupport Holding
The Chief Executive Officer, Emil Billbäck, made the biggest insider sale in the last 12 months. That single transaction was for kr60m worth of shares at a price of kr346 each. So we know that an insider sold shares at around the present share price of kr323. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive). Notably Emil Billbäck was also the biggest buyer, having purchased kr1.3m worth of shares.
In the last twelve months insiders purchased 4.75k shares for kr1.3m. But insiders sold 252.60k shares worth kr87m. Over the last year we saw more insider selling of Bonesupport Holding shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Check out our latest analysis for Bonesupport Holding
I will like Bonesupport Holding better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
Does Bonesupport Holding Boast High Insider Ownership?
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that Bonesupport Holding insiders own 10% of the company, worth about kr2.2b. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
So What Does This Data Suggest About Bonesupport Holding Insiders?
Unfortunately, there has been more insider selling of Bonesupport Holding stock, than buying, in the last three months. Despite some insider buying, the longer term picture doesn't make us feel much more positive. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Bonesupport Holding. You'd be interested to know, that we found 2 warning signs for Bonesupport Holding and we suggest you have a look.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Valuation is complex, but we're here to simplify it.
Discover if Bonesupport Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:BONEX
Bonesupport Holding
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
Exceptional growth potential with flawless balance sheet.
Market Insights
Weekly Picks

An Undervalued 3.3Moz Gold Project in Canada

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves
The First Real Lidar Winner

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth
Recently Updated Narratives

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?
Northern Solar: Explosive earnings growth makes this solar story harder to ignore

50% ROE in a Burning Building
Popular Narratives
SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

